M2 and M3 muscarinic receptors are involved in enteric nerve-mediated contraction of the mouse ileum: Findings obtained with muscarinic-receptor knockout mouse

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 1, 2007, Pages

  Takeuchi, Tadayoshi ^a   Tanaka, Keisuke ^a   Nakajima, Hidemitsu ^a   Matsui, Minoru ^b   Azuma, Yasu Taka ^a  

^a Osaka Prefecture University   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Acetylcholine mediated phasic contraction; M2 and M3 receptor knockout mouse; Neurogenic response; Substance P mediated tonic contraction

Indexed keywords

ACETYLCHOLINE; ARGININE; ATROPINE; CAPSAICIN; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ A [4-10][5 TYROSINE 6,8,9 DEXTRO TRYPTOPHAN 10 LYSINE]; PAPAVERINE; SUBSTANCE P; TETRODOTOXIN; MUSCARINIC M4 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION; ILEUM CONTRACTION; IMMUNOREACTIVITY; MOUSE; MUSCLE RELAXATION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; ANIMAL; ILEUM; INNERVATION; INTESTINE INNERVATION; MOUSE MUTANT; PHYSIOLOGY; SMOOTH MUSCLE;

ACETYLCHOLINE; ANIMALS; ATROPINE; CAPSAICIN; ENTERIC NERVOUS SYSTEM; ILEUM; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; SUBSTANCE P;

EID: 33846135093     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00173.2006     Document Type: Article

References (42)

1. Bartho L, Benko R, Patacchini R, Petho G, Holzer-Petsche U, Holzer P, Lazar Z, Undi S, Illenyi L, Antal A, Horvath OP. Effects of capsaicin on visceral smooth muscle: a valuable tool for sensory neurotransmitter identification. Eur J Pharmacol 500: 143-157, 2004.
2. Bartho L, Santicioli P, Patacchini R, Maggi CA. Tachykininergic transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of NK2 receptors. Br J Pharmacol 105: 805-810, 1992.
3. Bornstein JC, Costa M, Grider JR. Enteric motor and interneuronal circuits controlling motility. Neurogastroenterol Motil 16, Suppl 1: 34-38, 2004.
4. Cao W, Pricolo VE, Zhang L, Behar J, Biancani P, Kirber MT. Gq-linked NK(2) receptors mediate neurally induced contraction of human sigmoid circular smooth muscle. Gastroenterology 119: 51-61, 2000.
5. Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50: 279-290, 1998.
6. Eglen RM. Muscarinic receptors and gastrointestinal tract smooth muscle function. Life Sci 68: 2573-2578, 2001.
7. Eglen RM, Hegde SS, Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 48: 531-565, 1996.
8. Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa H, Taketo MM, Watanabe M, Manabe T, Kano M. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur J Neurosci 19: 2682-2692, 2004.
9. Furness JB. The Enteric Nervous System. Victoria, Australia: Blackwell, 2006.
10. Griffin MT, Ehlert FJ. Specific inhibition of isoproterenol- stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle. J Pharmacol Exp Ther 263: 221-225, 1992.
11. Hata F, Takeuchi T, Nishio H, Fujita A. Mediators and intracellular mechanisms of NANC relaxation of smooth muscle in the gastrointestinal tract. J Smooth Muscle Res 36: 181-204, 2000.
12. Honda K, Takano Y, Kamiya H. Pharmacological profiles of muscarinic receptors in the longitudinal smooth muscle of guinea pig ileum. Jpn J Pharmacol 62: 43-47, 1993.
13. 2 acetylcholine receptor distribution in the guinea-pig gastrointestinal tract. Neuroscience 138: 549-559, 2006.
14. Jankovic SM, Milovanovic D, Matovic M, and Iric-Cupic V. The effects of excitatory amino acids on isolated gut segments of the rat. Pharmacol Res 39: 143-148, 1999.
15. Karasawa H, Taketo MM, Matsui M. Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4. Eur J Pharmacol 468: 15-19, 2003.
16. Lecci A, Santicioli P, Maggi CA. Pharmacology of transmission to gastrointestinal muscle. Curr Opin Pharmacol 2: 630-641, 2002.
17. Maggi CA, Giuliani S, Ballati L, Lecci A, Manzini S, Patacchini R, Renzetti AR, Rovero P, Quartara L, Giachetti A. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J Pharmacol Exp Ther 257: 1172-1178, 1991.
18. Matsui M, Motomura D, Fujikawa T, Jiang J, Takahashi S, Manabe T, Taketo MM. Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J Neurosci 22: 10627-10632, 2002.
19. Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, Takahashi S, Taketo MM. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA 97: 9579-9584, 2000.
20. Matsui M, Yamada S, Oki T, Manabe T, Taketo MM, Ehlert FJ. Functional analysis of muscarinic acetylcholine receptors using knockout mice. Life Sci 75: 2971-2981, 2004.
21. McElroy AB, Clegg SP, Deal MJ, Ewan GB, Hagan RM, Ireland SJ, Jordan CC, Porter B, Ross BC, Ward P, et al. Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor. J Med Chem 35: 2582-2591, 1992.
22. Morita K, North RA, Katayama Y. Evidence that substance P is a neurotransmitter in the myenteric plexus. Nature 287: 151-152, 1980.
23. Okada Y, Hara A, Ma H, Xiao CY, Takahata O, Kohgo Y, Narumiya S, Ushikubi F. Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: studies using mice deficient in prostanoid receptors. Br J Pharmacol 131: 745-755, 2000.
24. Saban R, Nguyen N, Saban MR, Gerard NP, Pasricha PJ. Nerve-mediated motility of ileal segments isolated from NK(1) receptor knockout mice. Am J Physiol Gastrointest Liver Physiol 277: G1173-G1179, 1999.
25. Satoh Y, Uchida M, Fujita A, Nishio H, Takeuchi T, Hata F. Possible role of orexin A in nonadrenergic, noncholinergic inhibitory response of muscle of the mouse small intestine. Eur J Pharmacol 428: 337-342, 2001.
26. Schmidt P, Rasmussen TN, Holst JJ. Nervous control of the release of substance P and neurokinin A from the isolated perfused porcine ileum. J Auton Nerv Syst 38: 85-95, 1992.
27. Shi XZ, Sarna SK. Inflammatory modulation of muscarinic receptor activation in canine ileal circular muscle cells. Gastroenterology 112: 864-874, 1997.
28. 3-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol Regul Integr Comp Physiol 282: R1443-R1449, 2002.
29. Szolcsanyi J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 38: 377-384, 2004.
30. Takeuchi T, Fujinami K, Fujita A, Okishio Y, Takewaki T, Hata F. Essential role of the interstitial cells of Cajal in nitric oxide-mediated relaxation of longitudinal muscle of the mouse ileum. J Pharmacol Sci 95: 71-80, 2004.
31. Takeuchi T, Fujinami K, Goto H, Fujita A, Taketo MM, Manabe T, Matsui M, Hata F. Roles of M2 and M4 muscarinic receptors in regulating acetylcholine release from myenteric neurons of mouse ileum. J Neurophysiol 93: 2841-2848, 2005.
32. 2 muscarinic receptors in relaxant response of circular muscle of mouse gastric antrum. Neurogastroenterol Motil 18: 226-233, 2006.
33. Thomas EA, Baker SA, Ehlert FJ. Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum. Mol Pharmacol 44: 102-110, 1993.
34. Trendelenburg AU, Meyer A, Wess J, Starke K. Distinct mixtures of muscarinic receptor subtypes mediate inhibition of noradrenaline release in different mouse peripheral tissues, as studied with receptor knockout mice. Br J Pharmacol 145: 1153-1159, 2005.
35. 2+ channel current in smooth muscle cells of guinea-pig ileum. J Physiol 484: 567-581, 1995.
36. 3 muscarinic receptor-mediated contractions in longitudinal smooth muscle of the ileum studied with receptor knockout mice. Br J Pharmacol 146: 98-108, 2005.
37. Vannucchi MG and Faussone-Pellegrini MS. NK1, NK2 and NK3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse. Anat Embryol (Berl) 202: 247-255, 2000.
38. Ward SM, Sanders KM, Hirst GD. Role of interstitial cells of Cajal in neural control of gastrointestinal smooth muscles. Neurogastroenterol Motil 16, Suppl 1: 112-117, 2004.
39. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10: 69-99, 1996.
40. Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 44: 423-450, 2004.
41. Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Deng CX, Wess J. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410: 207-212, 2001.
42. Zhang W, Basile AS, Gomeza J, Volpicelli LA, Levey AI, Wess J. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci 22: 1709-1717, 2002.